POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 57 filers reported holding POSEIDA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,197,321 | +58.4% | 503,076 | +17.1% | 0.00% | – |
| Q2 2023 | $756,054 | -5.9% | 429,576 | +64.7% | 0.00% | – |
| Q1 2023 | $803,098 | -42.7% | 260,746 | -1.4% | 0.00% | – |
| Q4 2022 | $1,402,258 | +53.1% | 264,577 | +2.0% | 0.00% | – |
| Q3 2022 | $916,000 | +167.8% | 259,291 | +95.8% | 0.00% | – |
| Q2 2022 | $342,000 | -65.3% | 132,419 | -39.8% | 0.00% | – |
| Q1 2022 | $987,000 | -31.6% | 220,090 | +3.9% | 0.00% | – |
| Q4 2021 | $1,443,000 | -5.3% | 211,761 | +1.4% | 0.00% | – |
| Q3 2021 | $1,524,000 | +18.7% | 208,935 | +63.1% | 0.00% | – |
| Q2 2021 | $1,284,000 | -5.0% | 128,065 | -9.5% | 0.00% | – |
| Q1 2021 | $1,352,000 | +37.7% | 141,516 | +58.2% | 0.00% | – |
| Q4 2020 | $982,000 | +25.7% | 89,478 | +1.7% | 0.00% | – |
| Q3 2020 | $781,000 | – | 87,978 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,043,267 | $9,254,000 | 2.96% |
| SECTORAL ASSET MANAGEMENT INC | 1,053,779 | $9,347,000 | 0.80% |
| Pentwater Capital Management LP | 4,879,490 | $43,281,000 | 0.56% |
| Vivo Capital, LLC | 926,449 | $8,218,000 | 0.48% |
| Boxer Capital, LLC | 1,251,055 | $11,097,000 | 0.38% |
| Ikarian Capital, LLC | 228,000 | $2,022,000 | 0.15% |
| Perceptive Advisors | 787,745 | $6,987,000 | 0.10% |
| Rock Springs Capital Management LP | 367,499 | $3,260,000 | 0.08% |
| PURA VIDA INVESTMENTS, LLC | 148,949 | $1,321,000 | 0.07% |
| PIPER SANDLER & CO. | 8,298 | $74,000 | 0.06% |